Abstract
Introduction

1
Korea is moving toward an aged society with over 14% of the population aged 65 and older, which is higher than the global 2 percentage of over 7% of the population aged 65 and older, along with experiencing rapid social and economic progress. In 3 1980, the population of Koreans aged 65 and older was only 3.8%, but increased to 13.0% in 2015 and is expected to surge to super-aged society (with over 217% of the population aged 65 and older) from an aging society, while England took 100 8 years and the United States took 89 years. In contrast, the rate at which the Asian countries are expected to become a super-9 aged society is much higher than Western countries: China (34 years), Thailand (35 years), Japan (37 years), and South
10
Korea with the fastest rate among all Asian countries (27 years).
11
Parkinson's disease (PD) is a typical degenerative brain disease with four cardinal motor symptoms including bradykinesia, 12 tremor, rigidity, and gait disturbance as well as various non-motor symptoms. 3 As the disease progresses, it causes loss of 13 independence of gait and daily activities resulting in a bed-ridden state and even death. Due to these problems, PD has been 14 one of the major health problems causing social and economic burden in developed countries. 4 Although the prevalence and 15 incidence of the disease may vary depending on the country and study, the general trend shows an increase in the prevalence 16 and incidence as the population ages. 3, [5] [6] [7] [8] [9] [10] [11] This phenomenon is believed to further increase as the average life expectancy 17 increases.
18
Until recently, there has been no nationwide epidemiologic study on patients with PD in South Korea. Therefore, we used the 19 database from the National Health Insurance Service system to analyze changes in the prevalence, incidence, P/I ratio, major 20 causes of death, and hazard ratio (HR) for death in PD patients. The main aim of this study was to determine the prevalence,
21
incidence, and P/I ratio of PD in South Korea. These results may help accurately assess the efficiency of the current geriatric 22 health care policy in South Korea, and provide information to aid in the development of a new policy for PD patients.
24
Materials and Methods
25
Data Sources
26
The Korean National Health Insurance Service Corporation (KNHIS) has been distributing the National Health Information 
7
In addition, we used the NHID cohort in 2008 to determine the 5-year survival rate for the main causes of death and the 8 hazard ratios of PD itself and comorbidities from 2008 to 2013 (Fig. 1) . The major causes of death were compared in PD 9 patients and subjects without PD, while the hazard ratios were obtained by comparison to the control population without PD.
11
Statistics
12
The statistical package SAS for Windows, version 9.4 (SAS Inc, Cary, NC, USA) was used to analyze the data. P < 0.05 13 was defined as statistically significant. We used the Breslow-Day test to verify yearly changes in the prevalence, incidence,
14
and P/I ratio. We used multiple Cox proportional hazard regression models to obtain the hazard ratios of PD itself and 15 comorbidities. The survival curve estimate in subjects with and without PD was obtained using the Kaplan-Meier method.
16
17 Table 1 
Results
18
26
The P/I ratio has increased with age for 11 years from 2003 to 2013 (Table 2 ). The ratio in all subjects changed from 2.22 27 in 2003 to 3.62 in 2013, which was statistically significant (p<0.0001). There has also been a gradual increase in the yearly 28 change in the ratio in both the male and female population with statistical significance (p=0.0036 and p<0.0001, respectively) 1 from 2003 to 2013. When comparing the ratio between the male and female population, the female population had a higher 2 P/I ratio every year. We also compared the yearly change in P/I ratio in each age group by decade and found that the female 3 group in the 70s and in the 80s and older showed a gradual increase in the P/I ratio with statistical significance (p=0.0108 and 4 p<0.001) as the year progressed, while the male group did not show an increase in any age group.
5
The results of the major causes of death and hazard ratios of death based on the analysis from 2008 to 2013 are shown in 6   Table 3 . The major causes of death in the total population were cancer (6,943 deaths/24,559 total deaths; 28.27%), stroke 7 (2,221 deaths; 9.04%), ischemic heart disease (1,253 deaths; 5.10%), pneumonia (805 deaths; 3.28%), and other heart 8 disease. On the other hand, stroke was the most frequent cause of death in patients with PD (51 deaths/408 total deaths; 9 12.5%), followed by cancer (44 deaths; 10.78%), pneumonia (15 deaths; 3.68%), and ischemic heart disease (14 deaths; 10 3.43%).
11 Table 4 shows that the hazard ratio of death was much higher in PD patients compared with subjects without PD (HR: 12 15.36). The survival rate was 95% or more in subjects without PD, but dropped to less than 70% in patients with PD after 13 1,500 days since January 1, 2008 (Fig. 2) . Analysis of the hazard ratio of comorbidities within the patient population showed 14 that the hazard ratio of stroke was the highest at 18.56, followed by pneumonia at 15.05, ischemic heart disease at 8.99, and 15 non-ischemic heart disease at 5.65. 
23
The ratio of prevalence to incidence (P/I ratio) in PD is a useful tool that reflects the average duration of survival and 24 quality of management for the disease. Furthermore, a study in Taiwan found a different result from ours despite a biologically similar study population, using a 11 similar methodology, and operating under a national health insurance system like South Korea. 8 These different results may 12 be due to demographic characteristics, occupational and environmental differences, and genetic factors.
13
In the analysis of major causes of death in PD patients, stroke was first, cancer second, pneumonia third, and ischemic 14 heart disease fourth (Table 3 ). In contrast, the major causes of death in the entire sampled population were cancer first,
15
followed by cerebral stroke second, ischemic heart disease third, and pneumonia fourth. In addition, the hazard ratio of PD 16 itself to death was 15.36, indicating that the survival rate of patients with PD in our study was significantly lower than in 17 subjects without PD (Fig. 2) . A similar result was obtained from a study in Taiwan using a door-to-door survey method. 1 
18
They showed that the relative risk of death in PD patients versus non-PD was 3.38, and the fatality rate for PD after a 7-year 19 follow-up was 40.4%. This previous study also found that the survival rate of patients older than 65 years was significantly 20 lower than that of patients aged 40 to 65 years. 1 Another study on a European population also reported an increased mortality 21 rate in patients with PD over 70 years old. 3 
22
In terms of the hazard ratio of comorbidities leading to death in PD patients (Table 4) , the hazard ratio of stroke was the 23 highest at 18.56, followed by pneumonia at 15.05, ischemic heart disease at 8.99, and non-ischemic heart disease at 5.65,
24
indicating that the comorbidities of stroke or pneumonia in PD patients had the greatest influence on death. 
4
There has not yet been any report on the hazard ratios of PD itself and comorbidities in PD patients. Therefore, this report 5 is valuable for its contribution to understanding of the characteristics of comorbidities leading to death in patients with PD.
6
We were also interested in the rate of fractures from falling, which is common among PD patients due to motor symptoms 7 and postural instability 22 , but there was no difference in mortality from falls and fractures between the PD patient population 8 and the population without PD. An assumption can be made that this phenomenon is due to most end-stage PD patients being 9 bed-ridden, remarkably decreasing the risk of falls and fractures.
10
Since this was a retrospective cohort study, there was a limitation in this research because the diagnosis of PD was only 11 determined by the KCD code, making it impossible to apply the same diagnostic criteria as a prospective study.
12
The strong points of our study are as follows. Our study was the first in Korea to report the prevalence and incidence, P/I 13 ratio, major causes of death, and hazard ratio of death in PD patients utilizing a nationwide health insurance database. We 14 were able to include a large population for our study while previous studies only included door-to-door surveys or to 2013, we found that the annual prevalence, incidence, and P/I ratio of PD increased as the years progressed and were 24 higher in women than men. This indirectly proves that the health insurance or welfare system in Korea is efficient and has 25 allowed patients with PD to more easily utilize medical facilities or public services. Also, from the NHIS-NSC data from 26
2008 to 2013, we found that the leading cause of death in patients with PD was stroke, while cancer was the leading cause in 27 the entire sampled population. The hazard ratio of death in PD patients was very high at 15.36. Stroke and pneumonia were 28 the two major comorbidities causing death in PD patients. This is a somewhat different pattern from that of subjects without 1 PD, suggesting that a new public health strategy should be established for patients with PD.
2
We hope that the results of this study will be useful for comparing epidemiologic data with other countries and verifying 
